Haemonetics Corp is a health care company.It provides products to customers involved in the processing,handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes & reduce costs.
Website: | www.haemonetics.com |
Main Phone: | +1 781 848-7100 |
Address: | 400 Wood Road |
State: | MA |
City / Town: | Braintree |
Country: | USA |
Postal Code: | 02184-9114 |
Exchange: | NYE |
Employees: | 3225 |
NAICS: | Surgical and Med |
Last Price 76.26 | Change $ 0.52 | Change % 0.69 | Tick N/A |
Bid 76.05 | Bid Size 100.00 | Ask 76.16 | Ask Size 200.00 |
Open 75.51 | High 76.38 | Low 75.51 | Prev Close 75.74 |
Last Trade | Volume 35,402 | 52 Wk Hi 76.27 | 52 Wk Low 38.47 |
Market Cap 4.1 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares 53,447,550.00 | EPS (TTM) -0.35 | PE Ratio N/A | Exchange NYSE |
|
|
Last 3 Mo | Last 12 Mo | |
---|---|---|
Number of Insider Trades | 30 | 56 |
Number of Buys | 8 | 21 |
Number of Sells | 22 | 35 |
Net Activity | 124155 | 191846 |
Last 10 Buys | Shares |
---|---|
Christopher Simon | 1,000 |
Peter M. Allen | 1,000 |
Dave Helsel | 1,000 |
Jonathan White | 1,000 |
Sandra L. Jesse | 1,000 |
Christopher J. Lindop | 1,000 |
Joseph J. Forish | 1,000 |
Susan M. Hanlon | 1,000 |
Peter M. Allen | 1,000 |
Susan M. Hanlon | 1,000 |
Last 10 Sell | Shares |
---|---|
Ronald L. Merriman | 1,000 |
Ronald L. Merriman | 1,000 |
Ronald L. Merriman | 1,000 |
Ronald L. Merriman | 1,000 |
Ronald L. Merriman | 1,000 |
Ronald L. Merriman | 1,000 |
Ronald L. Merriman | 1,000 |
Ronald L. Merriman | 1,000 |
Ronald L. Merriman | 1,000 |
Ronald L. Merriman | 1,000 |
Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
---|---|---|---|---|
High Target Price Estimate | 46 | 46 | 46 | 46 |
Low Target Price Estimate | 32 | 32 | 25 | 32 |
Mean Target Price Estimate | 36.14 | 35.67 | 31.67 | 36.14 |
Standard Deviation | 5.61 | 5.99 | 7.55 | 5.61 |
Date of Most Recent Estimate | 08/15/16 | 08/02/16 | 05/18/16 | 08/15/16 |
Form Type | Form Description | Pages | Date |
---|---|---|---|
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-19 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-18 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-16 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-08 |
10-Q | Quarterly report with a continuing view of a company's financial position | 75 | 2016-08-01 |
8-K | Report of unscheduled material events or corporate changes. | 20 | 2016-08-01 |
8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-07-27 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-25 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-25 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-25 |
Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|
Strong Buy | 2 | 3 | 3 | 3 |
Moderate Buy | 0 | 0 | 0 | 0 |
Hold | 6 | 4 | 4 | 4 |
Moderate Sell | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 |
Mean Rec. | 2.78 | 2.5 | 2.5 | 2.5 |